Novel Imaging and Therapeutic Nanoparitcles
Main Advantages of this InventionΓÇóCan be used to treat a wide variety of diseases (Cancer, AIDS, Infectious diseases)ΓÇóFlexible constructΓÇóImproved nanoparticle design and versatility over current ones.
Potential Areas of Application ΓÇó Drug deliveryΓÇó Medical imagingΓÇó Personalized medicine
None
Patent Number: US8916135B2
Application Number: US2008197061A
Inventor: Boyes, Stephen G. | Rowe, Misty D. | Thamm, Douglas H. | Kraft, Susan L.
Priority Date: 22 Aug 2007
Priority Number: US8916135B2
Application Date: 22 Aug 2008
Publication Date: 23 Dec 2014
IPC Current: A61K004906 | A61K004918 | B82Y000500 | C07F000500 | A61B0005055
US Class: 424009322
Assignee Applicant: Colorado School of Mines,Golden | Colorado State University Research Foundation,Fort Collins
Title: Lanthanide nanoparticle conjugates and uses thereof
Usefulness: Lanthanide nanoparticle conjugates and uses thereof
Summary: In pharmaceutical compositions and for targeting, treating and/or imaging a disease or disorder in a patient (claimed). The disease or disorder includes cancer. Also useful for a wide variety of different drug delivery applications, such as gene therapy, imaging applications, such as vascular imaging, and even in external molecular detection devices, such as microarrays and assays.
Novelty: New gadolinium nanoparticle conjugate for targeting, imaging or treating e.g. cancer, comprises a gadolinium nanoparticle grafted onto a polymer or polymer precursor having a functional group as point of attachment to the nanoparticle
Disease Diagnostic/Treatment
Cancer/Tumor
USA
